Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabella Ogorek

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Bioorganic & Medicinal Chemistry Letters|May 28, 2013
Membrane anchoring γ-secretase modulators with terpene-derived moietiesEva Christine Naumann, Stefan Göring, Isabella Ogorek, et al.
Acta Neuropathologica Communications|October 21, 2018
Glycoprotein NMB: a novel Alzheimer's disease associated marker expressed in a subset of activated microgliaMelanie Hüttenrauch, Isabella Ogorek, Hans Klafki, et al.
Alzheimer'S Research & Therapy|May 5, 2021
Evaluation of cerebrospinal fluid glycoprotein NMB (GPNMB) as a potential biomarker for Alzheimer's diseaseFreyja Aichholzer, Hans-Wolfgang Klafki, Isabella Ogorek, et al.
Bioorganic & Medicinal Chemistry Letters|February 22, 2018
Discovery and validation of 2-styryl substituted benzoxazin-4-ones as a novel scaffold for rhomboid protease inhibitorsParul Goel, Thorsten Jumpertz, Anežka Tichá, et al.
Bioorganic & Medicinal Chemistry Letters|January 11, 2015
SAR-studies of γ-secretase modulators with PPARγ-agonistic and 5-lipoxygenase-inhibitory activity for Alzheimer's diseaseDaniel Flesch, Julia Ness, Christina Lamers, et al.
The Journal of Biological Chemistry|July 2, 2023
Pathogenic Aβ production by heterozygous PSEN1 mutations is intrinsic to the mutant protein and not mediated by conformational hindrance of wild-type PSEN1Vanessa Kurth, Isabella Ogorek, Carolina Münch, et al.
Oncotarget|June 2, 2018
Inhibition of Wnt/beta-catenin signaling downregulates expression of aldehyde dehydrogenase isoform 3A1 (ALDH3A1) to reduce resistance against temozolomide in glioblastoma <i>in vitro</i>Abigail Kora Suwala, Katharina Koch, Dayana Herrera Rios, et al.
Biochemistry|November 30, 2017
Discovery and Biological Evaluation of Potent and Selective N-Methylene Saccharin-Derived Inhibitors for Rhomboid Intramembrane ProteasesParul Goel, Thorsten Jumpertz, David C Mikles, et al.
Plos One|March 4, 2014
Blood platelets in the progression of Alzheimer's diseaseNina S Gowert, Lili Donner, Madhumita Chatterjee, et al.
Acta Neuropathologica|November 15, 2018
The metalloprotease ADAMTS4 generates N-truncated Aβ4-x species and marks oligodendrocytes as a source of amyloidogenic peptides in Alzheimer's diseaseSusanne Walter, Thorsten Jumpertz, Melanie Hüttenrauch, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Bioorganic & Medicinal Chemistry Letters|May 28, 2013
Membrane anchoring γ-secretase modulators with terpene-derived moietiesEva Christine Naumann, Stefan Göring, Isabella Ogorek, et al.
Acta Neuropathologica Communications|October 21, 2018
Glycoprotein NMB: a novel Alzheimer's disease associated marker expressed in a subset of activated microgliaMelanie Hüttenrauch, Isabella Ogorek, Hans Klafki, et al.
Alzheimer'S Research & Therapy|May 5, 2021
Evaluation of cerebrospinal fluid glycoprotein NMB (GPNMB) as a potential biomarker for Alzheimer's diseaseFreyja Aichholzer, Hans-Wolfgang Klafki, Isabella Ogorek, et al.
Bioorganic & Medicinal Chemistry Letters|February 22, 2018
Discovery and validation of 2-styryl substituted benzoxazin-4-ones as a novel scaffold for rhomboid protease inhibitorsParul Goel, Thorsten Jumpertz, Anežka Tichá, et al.
Bioorganic & Medicinal Chemistry Letters|January 11, 2015
SAR-studies of γ-secretase modulators with PPARγ-agonistic and 5-lipoxygenase-inhibitory activity for Alzheimer's diseaseDaniel Flesch, Julia Ness, Christina Lamers, et al.
The Journal of Biological Chemistry|July 2, 2023
Pathogenic Aβ production by heterozygous PSEN1 mutations is intrinsic to the mutant protein and not mediated by conformational hindrance of wild-type PSEN1Vanessa Kurth, Isabella Ogorek, Carolina Münch, et al.
Oncotarget|June 2, 2018
Inhibition of Wnt/beta-catenin signaling downregulates expression of aldehyde dehydrogenase isoform 3A1 (ALDH3A1) to reduce resistance against temozolomide in glioblastoma <i>in vitro</i>Abigail Kora Suwala, Katharina Koch, Dayana Herrera Rios, et al.
Biochemistry|November 30, 2017
Discovery and Biological Evaluation of Potent and Selective N-Methylene Saccharin-Derived Inhibitors for Rhomboid Intramembrane ProteasesParul Goel, Thorsten Jumpertz, David C Mikles, et al.
Plos One|March 4, 2014
Blood platelets in the progression of Alzheimer's diseaseNina S Gowert, Lili Donner, Madhumita Chatterjee, et al.
Acta Neuropathologica|November 15, 2018
The metalloprotease ADAMTS4 generates N-truncated Aβ4-x species and marks oligodendrocytes as a source of amyloidogenic peptides in Alzheimer's diseaseSusanne Walter, Thorsten Jumpertz, Melanie Hüttenrauch, et al.
Pageof 1